Profile cover photo
Profile photo
Gavin Giovannoni
221 followers -
Clinical academic dedicated to multiple sclerosis who loves food, wine, his family and running
Clinical academic dedicated to multiple sclerosis who loves food, wine, his family and running

221 followers
About
Posts

Post has attachment
Guest post: MSexism 2 - gender bias in the MS community
Women experts launch a call to action to end gender bias in the MS community. More than one hundred female academic neurologists and neuroscientists worldwide have called on pharmaceutical companies, MS conference organisers and journal editorial boards to ...
Guest post: MSexism 2 - gender bias in the MS community
Guest post: MSexism 2 - gender bias in the MS community
multiple-sclerosis-research.blogspot.com
Add a comment...

Post has attachment
Unrelated Comments & Questions - November 2018
Sometimes you want to say something unrelated to the thread or ask a clinical question or some other MS-related question that has not been answered in past.  This is the place for you.
Unrelated Comments & Questions - November 2018
Unrelated Comments & Questions - November 2018
multiple-sclerosis-research.blogspot.com
Add a comment...

Post has attachment
Why is Prof G dissatisfied?
I have been espousing the message that time is Brain in the treatment of MS, but the NHS makes it difficult to practice what you preach. MS services in the NHS are not configured at present to react quickly in terms of new referrals and as a result, MSers p...
Add a comment...

Post has attachment
Treating carry-over PML after immunodepletion
Treating PML in the presence of immunodepletion is not necessarily a death sentence. There are some solutions on the horizon.  At present we don't have an anti-viral agent that works against the JC virus that causes PML (progressive multifocal leukoencephal...
Treating carry-over PML after immunodepletion
Treating carry-over PML after immunodepletion
multiple-sclerosis-research.blogspot.com
Add a comment...

Post has attachment
triMS-online: helping female academics
Another development at ECTRIMS 2018 that I heard about via the grapevine is that female academics are mobilising and have formed a group to demand gender equality at the top table of MS academia. Good! Apparently, our posts on this blog ( MS Establishment )...
triMS-online: helping female academics
triMS-online: helping female academics
multiple-sclerosis-research.blogspot.com
Add a comment...

Post has attachment
Early reflections on ECTRIMS 2018
I am writing this post on the flight back to London from Berlin. Being trapped in a tin tube at over 10,000m above sea level is always a good time to think. under & over - ProfG's #1 non-scientific highlight at #ECTRIMS2018 Any guesses what my #1_scientific...
Early reflections on ECTRIMS 2018
Early reflections on ECTRIMS 2018
multiple-sclerosis-research.blogspot.com
Add a comment...

Post has attachment
Is it time to reunify MS as one disease?
I am just about to leave Berlin tired but content that the MS world is finally beginning to acknowledge that #MS_is_1_and_not_2_or_3_diseases . We have covered this topic extensively over the last 4-5 years and I did so again in my talk as part of the Roche...
Is it time to reunify MS as one disease?
Is it time to reunify MS as one disease?
multiple-sclerosis-research.blogspot.com
Add a comment...

Post has attachment
ECTRIMS 2018: will Berlin turn into a new battle ground
I arrived in Berlin yesterday and already I am seeing ECTRIMS 2018 turning into a battle over the lumpers and splitters, i.e. is MS one, two or three diseases.  Battle of Berlin Roche , who has ocrelizumab licensed for relapsing and primary progressive MS w...
ECTRIMS 2018: will Berlin turn into a new battle ground
ECTRIMS 2018: will Berlin turn into a new battle ground
multiple-sclerosis-research.blogspot.com
Add a comment...

Post has attachment
ProfG's MS-related Twitter activity: week 1st-7th October 2018
It is a draw interferon-beta 1 vs. glatiramer acetate 1. #ClinicSpeak There is no difference in the comparative effectiveness between the beta-interferons and glatiramer acetate. But what about the other attributes, e.g. pregnancy, NABs, monitoring, etc. ? ...
Add a comment...

Post has attachment
ProfG are you walking-your-talk or just huffing-and-puffing?
I was asked after my ' ProfG is fuming ' blog post from a few weeks ago, if I was walking-my-talk and doing something about NICE's decision about ocrelizumab for PPMS or just huffing-and-puffing and doing nothing about it. My response was yes; I am walking-...
ProfG are you walking-your-talk or just huffing-and-puffing?
ProfG are you walking-your-talk or just huffing-and-puffing?
multiple-sclerosis-research.blogspot.com
Add a comment...
Wait while more posts are being loaded